 |
인쇄하기
취소
|
Leading drug makers’ outpatient sales drop in 2012
Korea's ten leading companies witnessed their outpatient sales tumble last year from a year earlier, data showed Monday.
Outpatient sales by ten companies stood at 2.69 trillion won last year, down 10.8 percent from 3.22 trillion won in 2011, according to CEO Score, a website for evaluating chaebol and CEOs.
However, the ratio of their other products’ sales rose 15.9 percent on-year to 1....
Outpatient sales by ten companies stood at 2.69 trillion won last year, down 10.8 percent from 3.22 trillion won in 2011, according to CEO Score, a website for evaluating chaebol and CEOs.
However, the ratio of their other products’ sales rose 15.9 percent on-year to 1....
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.